PARIS (Reuters) -French medical regulator HAS said on Thursday it had approved the vaccine developed by Pfizer and BioNTech for France’s vaccination rollout, after the European Medicines Agency gave its go-ahead on Monday.
“The vaccine can be used for people aged 16 and over, including elderly”, the regulator says.
The European Union is gearing up for a vaccination campaign of unprecedented scale following regulatory approval for the shot. France plans to start its vaccination programme on Dec. 27.
(Reporting by Matthieu Protard; Editing by Edmund Blair)
